2024-10-07 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis Report

**1. Performance and Relative Strength:**

HCA Healthcare Inc. (HCA) is a leading provider of healthcare services in the United States. The company has significantly outperformed the S&P 500 (VOO) over the period under consideration. 

* **Cumulative Return:** HCA: 321.43%, VOO: 133.14%
* **Divergence:** The current divergence between HCA and VOO is 188.29, representing a relative strength of 93.43%. This indicates that HCA has outperformed the S&P 500 by a significant margin compared to its historical performance range.

**2. Recent Price Action:**

* **Closing Price:** $394.07
* **5-day Moving Average:** $400.45
* **20-day Moving Average:** $398.88
* **60-day Moving Average:** $374.67

The stock is currently trading below its 5-day and 20-day moving averages, indicating a potential short-term downtrend. However, it is still above its 60-day moving average, suggesting a potential long-term upward trend.

**3. Technical Indicators:**

* **RSI:** 36.53
* **PPO:** -0.57
* **Delta_Previous_Relative_Divergence:** -3.61 (short-term downtrend)
* **Expected Return:** 0.88% (5-year expected return, exceeding S&P 500 performance)

The RSI suggests the stock is currently in oversold territory, while the PPO indicates a potential downward momentum. However, the expected return remains positive, suggesting a potential for future growth.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | $17.49 Billion |
| 2024-05-02 | 6.01 | $17.34 Billion |
| 2023-10-26 | 3.98 | $16.21 Billion |
| 2023-08-02 | 4.35 | $15.86 Billion |
| 2024-07-29 | 4.35 | $15.86 Billion |

HCA's latest earnings report showed a strong performance, exceeding analysts' expectations. The company reported EPS of $5.6 and revenue of $17.49 billion, both surpassing estimates. This positive performance reflects the company's solid financial position and strong growth potential.

**5. News and Recent Issues:**

Recent market outlook for HCA remains positive. Analysts cite strong earnings, a robust healthcare market, and an aging population as key drivers for growth. 

**Analyst Opinions:**

* **FINBOLD:** HCA has been rated "Strong Buy" by analysts, with an average price target of $420. This indicates a potential upside of over 6% from the current price.
* **Other analysts:** Several other analysts have also expressed optimism about HCA's future, citing the company's strong market position, cost-cutting measures, and potential for further expansion.

**Performance Highlights:**

* **Strong earnings:** HCA consistently surpasses earnings estimates, demonstrating its solid financial performance and growth potential.
* **Market leadership:** As a leading player in the healthcare sector, HCA benefits from a strong market position and large customer base.
* **Aging population:** The growing aging population in the US will likely drive demand for healthcare services, supporting HCA's growth trajectory.

**6. Comprehensive Analysis:**

HCA Healthcare Inc. is a strong performer with a proven track record of success. The company's recent earnings, analyst opinions, and overall market outlook suggest a positive outlook for the future. While the stock is currently experiencing some short-term fluctuations, the long-term fundamentals remain strong. The company's strong financial position, robust market share, and growth potential make HCA an attractive investment option for investors seeking exposure to the healthcare sector.

**7. Conclusion:**

Based on the current data, HCA Healthcare Inc. (HCA) presents a compelling investment opportunity. The company's strong financial performance, market leadership, and positive market outlook suggest significant growth potential. While some short-term fluctuations may occur, the long-term fundamentals remain solid, making HCA a strong contender for investors seeking to capitalize on the growing healthcare sector. 
